We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

70 hedge funds and large institutions have $216M invested in ChemoCentryx, Inc. in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

8% more capital invested

Capital invested by funds: $200M → $216M (+$15.8M)

6% more call options, than puts

Call options by funds: $721K | Put options by funds: $680K

0% more funds holding

Funds holding: 7070 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
70
Holders Change
Holders Change %
0%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
27
Reduced
22
Closed
7
Calls
$721K
Puts
$680K
Net Calls
+$41K
Net Calls Change
+$9K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$59.8M -$8.21M -1,033,071 -12%
Capital World Investors
2
Capital World Investors
California
$28.5M
WA
3
Wasatch Advisors
Utah
$20.7M -$210K -26,374 -1%
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$18.5M +$3M +377,678 +20%
Franklin Resources
5
Franklin Resources
California
$13.7M
BFA
6
BlackRock Fund Advisors
California
$10.7M +$132K +16,606 +1%
Westfield Capital Management
7
Westfield Capital Management
Massachusetts
$9.25M -$1.17M -147,701 -12%
AG
8
Artal Group
Luxembourg
$7.41M +$794K +100,000 +13%
Vanguard Group
9
Vanguard Group
Pennsylvania
$7.12M +$131K +16,442 +2%
GCM
10
Gruss Capital Management
New York
$3.97M -$397K -50,000 -9%
RG
11
Redmile Group
California
$3.92M +$3.64M +458,793 +2,622%
EAM
12
EverPoint Asset Management
Connecticut
$3.54M +$3.42M +430,000 New
State Street
13
State Street
Massachusetts
$3.45M +$336K +42,295 +11%
Marshall Wace
14
Marshall Wace
United Kingdom
$2.33M +$437K +55,055 +24%
Northern Trust
15
Northern Trust
Illinois
$2.15M +$37.9K +4,767 +2%
A
16
Abingworth
United Kingdom
$1.77M +$837K +105,300 +96%
BIT
17
BlackRock Institutional Trust
California
$1.71M -$301K -37,900 -15%
PI
18
Putnam Investments
Massachusetts
$1.65M
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.39M +$456K +57,425 +51%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$1.18M +$28K +3,528 +3%
Renaissance Technologies
21
Renaissance Technologies
New York
$1.05M +$363K +45,677 +56%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$942K +$35.1K +4,419 +4%
BIM
23
BlackRock Investment Management
Delaware
$825K +$75.2K +9,464 +10%
TCIM
24
TIAA CREF Investment Management
New York
$820K -$164K -20,600 -17%
JP Morgan Chase
25
JP Morgan Chase
New York
$751K -$56.8K -7,150 -7%

CCXI Hedge Fund Activity: Q2 2015 in Review

70 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2015, worth a combined $216M — up 7.9% from $200M a quarter earlier.

Fund positioning in CCXI was balanced in Q2 2015: 7 funds opened new positions, 7 closed out, 27 added to existing stakes and 22 trimmed.

The largest buyer was Redmile Group, adding an estimated $3.64M. The largest seller was BVF Inc, cutting an estimated $8.21M.

  • 70 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $216M of ChemoCentryx, Inc. stock for Q2 2015, up 7.9% quarter-over-quarter.
  • 7 funds opened new ChemoCentryx, Inc. positions in Q2 2015 and 7 closed out, a net change of 0 holders.
  • The largest ChemoCentryx, Inc. buyer in Q2 2015 was Redmile Group, an estimated $3.64M added.
  • The largest ChemoCentryx, Inc. seller in Q2 2015 was BVF Inc, an estimated $8.21M sold.

Based on aggregated 13F filings for Q2 2015.